Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by Whittier Trust Co. of Nevada Inc.

Whittier Trust Co. of Nevada Inc. boosted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 45.8% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 33,806 shares of the medical equipment provider’s stock after buying an additional 10,626 shares during the quarter. Whittier Trust Co. of Nevada Inc.’s holdings in Intuitive Surgical were worth $17,645,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Atala Financial Inc purchased a new position in Intuitive Surgical during the 4th quarter worth approximately $25,000. Berbice Capital Management LLC purchased a new position in Intuitive Surgical during the 4th quarter worth approximately $26,000. BankPlus Trust Department purchased a new position in Intuitive Surgical during the 4th quarter worth approximately $28,000. Kohmann Bosshard Financial Services LLC purchased a new position in Intuitive Surgical during the 4th quarter worth approximately $31,000. Finally, Decker Retirement Planning Inc. purchased a new position in shares of Intuitive Surgical during the 4th quarter valued at approximately $36,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Down 0.1 %

Shares of ISRG opened at $491.81 on Friday. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00. The firm’s fifty day moving average is $563.34 and its two-hundred day moving average is $531.34. The stock has a market cap of $175.17 billion, a PE ratio of 76.73, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on ISRG. Erste Group Bank lowered shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Monday. Piper Sandler reaffirmed an “overweight” rating and set a $670.00 target price (up from $538.00) on shares of Intuitive Surgical in a report on Friday, January 24th. Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and lifted their target price for the company from $522.00 to $650.00 in a report on Monday, December 2nd. Barclays lifted their target price on shares of Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. Finally, Citigroup lifted their target price on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a report on Friday, January 24th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average price target of $611.86.

Insiders Place Their Bets

In other Intuitive Surgical news, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34. Following the sale, the chief financial officer now owns 2,630 shares of the company’s stock, valued at $1,502,019.30. The trade was a 3.45 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the business’s stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the transaction, the director now directly owns 12,275 shares in the company, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 33,754 shares of company stock valued at $17,691,621 in the last 90 days. 0.90% of the stock is owned by insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.